S100P and carcinoma: S100P expression has been linked to progression of malignancy of cells originating from numerous tissue sources, such as breast, pancreas and lung39–44 with supporting evidence showing that S100P acts a regulator of cellular invasiveness and motility in multiple human carcinoma cell lines23,31–33.